News
For older parents or parents struggling with certain medical conditions who want to have children, fertility treatment is a modern technological miracle. Doctors at Yale School of Medicine provide an array of services, while leading research with exciting clinical applications.
Research into clinical applications for prenatal gene therapy could offer hope to infants in the womb identified as developing grave conditions such as cystic fibrosis
For patients suffering from genetic disorders or diseases that may be cured by a combination of three new technologies, the clinical applications can’t come quickly enough.
The line between mental illness and genius has long been known to be razor-thin. Yale researchers stumbled upon evidence of this fragile boundary while researching auditory hallucinations in schizophrenia.
Yale researchers use a massive brain-tissue repository, or “brain bank,” at the VA’s National Center for PTSD to postulate generalizations about the genetic origins of the condition and its physiological characteristics.
Geneticist Monkol Lek, PhD, suffers from a rare disease, muscular dystrophy, which he also researches.
How researchers at Yale are complicating the picture of human health.
Faculty and administrators remember a beloved leader in the YSM community.
A new tool for gene editing offers new approaches to prevent disease.
A West Campus pioneer wonders why skin cancer doesn't spread in horses, cows, and pigs. The answer, surprisingly, relates to the evolution of mammalian pregnancy.
A reunion visit leads to a search for genetic clues to a brain disorder
Clinicians at the Child Study Center worked with experts in genetics, neuroimaging, and eye tracking to understand what causes childhood disintegrative disorder, a rare form of autism.
Jesse Rinehart had a protein he wanted to fabricate in bacteria; Farren Isaacs had the perfect bacterial factory. They moved next door to each other, and the rest is history.
Exome sequencing allows scientists and clinicians to zero in on the mutations responsible for a disparate array of ailments.
Carolyn Slayman died on December 27 after a bout with cancer.
A scientist looks for clues to cell regeneration.
Ken and Judy Kidd’s bank of 2,600 cell lines contains the secrets of our evolution and perhaps our future health—why would they destroy it?
